{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:35:21Z","timestamp":1790976921656,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jtoelsevier.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jtho.2015.11.005","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T06:51:08Z","timestamp":1453445468000},"page":"142-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":257,"title":["The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification"],"prefix":"10.1016","volume":"11","author":[{"given":"Francoise","family":"Galateau-Salle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Roggli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2015.11.005_bib1","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"10.1016\/j.jtho.2015.11.005_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart","volume":"10","author":"Travis","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2015.11.005_bib3","series-title":"World Health Organization Classification of Tumors.\u00a0Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.jtho.2015.11.005_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jtho.2015.11.005_bib5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the International Association for the Study of Lung Cancer Mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2015.11.005_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00428-014-1664-9","article-title":"Reproducibility of histological subtyping of malignant pleural mesothelioma","volume":"465","author":"Brcic","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtho.2015.11.005_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2012.39","article-title":"Pleomorphic mesothelioma: report of 10 cases","volume":"25","author":"Ordonez","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/JTO.0b013e318211127a","article-title":"Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma","volume":"6","author":"Kadota","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2015.11.005_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtho.2015.11.005_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/modpathol.2009.180","article-title":"Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases","volume":"23","author":"Klebe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/modpathol.2008.125","article-title":"Malignant\u00a0mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review","volume":"21","author":"Klebe","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib15","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.5858\/2005-129-1421-DDOBAM","article-title":"Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies","volume":"129","author":"Cagle","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtho.2015.11.005_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PAS.0000000000000176","article-title":"p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma","volume":"38","author":"Hwang","year":"2014","journal-title":"AmJ Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"136","author":"Churg","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtho.2015.11.005_bib19","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/PAS.0b013e31822a2481","article-title":"The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas","volume":"35","author":"Churg","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"24","author":"Churg","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/110.2.191","article-title":"The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining","volume":"110","author":"Mangano","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00428-015-1777-9","article-title":"The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma","volume":"467","author":"Thway","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtho.2015.11.005_bib23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000478-200404000-00013","article-title":"Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases","volume":"28","author":"Galateau-Sall\u00e9","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib24","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2559.2007.02794.x","article-title":"Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature","volume":"51","author":"Carlson","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.jtho.2015.11.005_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/gcc.20766","article-title":"Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors","volume":"49","author":"Salas","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jtho.2015.11.005_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A\u00a0nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib28","article-title":"Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma","author":"Krasinskas","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.jtho.2015.11.005_bib29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1309\/AJCPP5R2ZJZKCLWN","article-title":"The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations","volume":"135","author":"Monaco","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jcp.2010.076794","article-title":"FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma","volume":"63","author":"Chung","year":"2010","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib33","doi-asserted-by":"crossref","unstructured":"Hida T, Matsumoto S, Hamasaki M, et\u00a0al. p16 deletion status in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue [e-pub ahead of print]. Cancer Sci. http:\/\/dx.doi.org\/10.1111\/cas.12769, accessed December 21, 2015.","DOI":"10.1111\/cas.12769"},{"key":"10.1016\/j.jtho.2015.11.005_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1378\/chest.09-1951","article-title":"Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology","volume":"138","author":"Savic","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2015.11.005_bib35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncy.21342","article-title":"The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey","volume":"121","author":"Paintal","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","article-title":"Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas","volume":"453","author":"Dacic","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtho.2015.11.005_bib37","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Lopez-Rios","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2015.11.005_bib38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2015.11.005_bib39","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2015.11.005_bib40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtho.2015.11.005_bib41","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","article-title":"Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations","volume":"8","author":"Zauderer","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2015.11.005_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","article-title":"Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma","volume":"206","author":"Cheung","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jtho.2015.11.005_bib43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2015.11.005_bib44","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib45","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib46","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet? [e-pub ahead of print]","author":"Churg","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtho.2015.11.005_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2015.11.005_bib48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2015.11.005_bib49","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1309\/AJCPN25NJTOUNPNF","article-title":"Extensive survey of STAT6 expression in a large series of mesenchymal tumors","volume":"143","author":"Demicco","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib50","doi-asserted-by":"crossref","first-page":"98ra82","DOI":"10.1126\/scitranslmed.3002409","article-title":"Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma","volume":"3","author":"Tanas","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtho.2015.11.005_bib51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A\u00a0novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jtho.2015.11.005_bib52","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00000478-200105000-00019","article-title":"Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma","volume":"25","author":"Mendlick","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib53","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jtho.2015.11.005_bib54","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/PAS.0000000000000346","article-title":"Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on\u00a0pathologic grading and molecular studies of WWTR1-CAMTA1 fusions","volume":"39","author":"Anderson","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib55","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1378\/chest.11-0039","article-title":"Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer","volume":"140","author":"Lau","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2015.11.005_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/modpathol.3800272","article-title":"Nuclear beta-catenin in mesenchymal tumors","volume":"18","author":"Ng","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2015.11.005_bib57","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/cncr.28271","article-title":"CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study","volume":"119","author":"Colombo","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2015.11.005_bib58","series-title":"International Classification of Diseases for Oncology","author":"Fritz","year":"2000"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:41:23Z","timestamp":1718318483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1556086415000532"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2015.11.005","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2015.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}